ARCA biopharma (ABIO)
(Real Time Quote from BATS)
$3.49 USD
-0.14 (-3.86%)
Updated Apr 25, 2024 02:02 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
ARCA biopharma, Inc. [ABIO]
Reports for Purchase
Showing records 1 - 15 ( 15 total )
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
ValuEngine Detailed Valuation Report for ABIO
Provider: ValuEngine, Inc
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Termination of Coverage-Analyst(s) Departure
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
GENETIC-AF trial progressing-reported financial results for their Q1/2014 quarter
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: NAPODANO J
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: ARCA biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: NAPODANO J
|